{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:30:02Z","timestamp":1788870602493,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministerio de Ciencia, Innovacion y Universidades","award":["CP1500200"],"award-info":[{"award-number":["CP1500200"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Miguel Servet"},{"name":"Miguel Servet"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Research"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.neures.2020.11.004","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T09:35:26Z","timestamp":1607679326000},"page":"330-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Glial activation precedes alpha-synuclein pathology in a mouse model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"170","author":[{"given":"Maria","family":"Izco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Blesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Verona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Mark","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Alvarez-Erviti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neures.2020.11.004_bib0005","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/cddis.2011.17","article-title":"IFN-\u03b3 signaling, with the synergistic contribution of TNF-\u03b1, mediates cell specific microglial and astroglial activation in experimental models of Parkinson\u2019s disease","volume":"2","author":"Barcia","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neures.2020.11.004_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.parkreldis.2009.05.005","article-title":"[11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson\u2019s disease?","volume":"16","author":"Bartels","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neures.2020.11.004_bib0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11481-012-9401-0","article-title":"Microglial activation and antioxidant responses induced by the Parkinson\u2019s disease protein alpha-synuclein","volume":"8","author":"Beraud","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.neures.2020.11.004_bib0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nbd.2012.05.018","article-title":"The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study","volume":"48","author":"Blesa","year":"2012","journal-title":"Neurobiol. Disease"},{"key":"10.1016\/j.neures.2020.11.004_bib0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients","volume":"202","author":"Blum-Degen","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neures.2020.11.004_bib0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","article-title":"The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis","volume":"40","author":"Booth","year":"2017","journal-title":"Trends Neurosci. Educ."},{"key":"10.1016\/j.neures.2020.11.004_bib0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1602\/neurorx.1.2.243","article-title":"Neuroimaging in parkinson\u2019s disease","volume":"1","author":"Brooks","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.neures.2020.11.004_bib0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(97)00119-7","article-title":"Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat","volume":"79","author":"Colburn","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neures.2020.11.004_bib0045","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.it.2016.06.006","article-title":"Astrocytes: key regulators of neuroinflammation","volume":"37","author":"Colombo","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.neures.2020.11.004_bib0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1742-2094-8-166","article-title":"The acute inflammatory response to intranigral \u03b1-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation","volume":"8","author":"Couch","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neures.2020.11.004_bib0055","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.nbd.2009.11.018","article-title":"Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia\/ macrophage activation","volume":"37","author":"De Lella-Ezcurra","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neures.2020.11.004_bib0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/bmb\/ldl018","article-title":"Parkinson\u2019s disease and pesticide exposures","volume":"79-80","author":"Dick","year":"2012","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.neures.2020.11.004_bib0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0404.1999.tb00721.x","article-title":"Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism","volume":"100","author":"Dobbs","year":"1999","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neures.2020.11.004_bib0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12974-018-1171-z","article-title":"Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration","volume":"15","author":"Duffy","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neures.2020.11.004_bib0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-012-1004-6","article-title":"Protein degradation pathways in Parkinson\u2019s disease \u2013 curse or blessing","volume":"124","author":"Ebrahimi-Fakhari","year":"2012","journal-title":"Acta Neuropathology"},{"key":"10.1016\/j.neures.2020.11.004_bib0080","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.neures.2020.11.004_bib0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2006.06.013","article-title":"Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra","volume":"24","author":"Ferrari","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neures.2020.11.004_bib0090","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1126\/science.298.5593.556","article-title":"New insights into neuron-glia communication","volume":"298","author":"Fields","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neures.2020.11.004_bib0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/978-1-4939-3271-9_26","article-title":"Viral vector-based modeling of neurodegenerative disorders: parkinson\u2019s disease","volume":"1382","author":"Fischer","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neures.2020.11.004_bib0100","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","article-title":"Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis","volume":"74","author":"Gagne","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neures.2020.11.004_bib0105","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1289\/ehp.1003013","article-title":"Neuroinflammation and \u03b1-Synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of parkinson\u2019s disease","volume":"119","author":"Gao","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.neures.2020.11.004_bib0110","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neures.2020.11.004_bib0115","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nn.4222","article-title":"Microglial brain region-dependent diversity and selective regional sensitivities to aging","volume":"19","author":"Grabert","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neures.2020.11.004_bib0120","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1126\/science.1098966","article-title":"Biomedicine. Parkinson\u2019s\u2013divergent causes, convergent mechanisms","volume":"304","author":"Greenamyre","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neures.2020.11.004_bib0125","doi-asserted-by":"crossref","DOI":"10.1002\/ana.25557","article-title":"Increased immune activation by pathologic alpha-synuclein in Parkinson\u2019s Disease","author":"Grozdanov","year":"2019","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neures.2020.11.004_bib0130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mds.23455","article-title":"Glia: initiators and progressors of pathology in Parkinson\u2019s disease","volume":"26","author":"Halliday","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neures.2020.11.004_bib0135","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ng.642","article-title":"Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson\u2019s disease","volume":"42","author":"Hamza","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neures.2020.11.004_bib0140","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbrc.2016.09.109","article-title":"Alpha-synuclein activates BV2 microglia dependent on its aggregation state","volume":"479","author":"Hoffmann","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neures.2020.11.004_bib0145","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neures.2020.11.004_bib0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0162-3109(98)00022-8","article-title":"Microglial and astrocytic involvement in a murine model of Parkinson\u2019s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"39","author":"Kohutnicka","year":"1998","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.neures.2020.11.004_bib0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-5-8","article-title":"Neuroinflammation mediated by IL-1\u03b2 increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson\u2019s disease","volume":"5","author":"Koprich","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neures.2020.11.004_bib0160","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of \u03b1-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neures.2020.11.004_bib0165","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neures.2020.11.004_bib0170","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neures.2020.11.004_bib0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-3-15","article-title":"Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury","volume":"3","author":"Lin","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neures.2020.11.004_bib0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbi.2013.07.007","article-title":"Cerebrospinal fluid inflammatory markers in Parkinson\u2019s disease: associations with depression, fatigue, and cognitive impairment","volume":"33","author":"Lindqvist","year":"2013","journal-title":"Brain, Behav. Immun."},{"key":"10.1016\/j.neures.2020.11.004_bib0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/svn-2016-000012","article-title":"Neurotransmitter receptors on microglia","volume":"1","author":"Liu","year":"2016","journal-title":"Stroke Vasc. Neurol."},{"key":"10.1016\/j.neures.2020.11.004_bib0190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pneurobio.2009.08.001","article-title":"The influence of microglia on the pathogenesis of Parkinson\u2019s disease","volume":"89","author":"Long-Smith","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neures.2020.11.004_bib0195","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neures.2020.11.004_bib0200","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000325653","article-title":"Non-steroidal anti-inflammatory drug use and the risk of Parkinson\u2019s disease","volume":"36","author":"Manthripragada","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neures.2020.11.004_bib0205","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","article-title":"Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution","volume":"566","author":"Masuda","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neures.2020.11.004_bib0210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson\u2019s disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neures.2020.11.004_bib0215","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neures.2020.11.004_bib0220","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","article-title":"Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys","volume":"197","author":"Miklossy","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neures.2020.11.004_bib0225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1\u03b2, interleukin-6, epidermal growth factor and transforming growth factor-\u03b1 are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neures.2020.11.004_bib0230","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/jnc.13684","article-title":"The astrocytic response to the dopaminergic denervation of the striatum","volume":"139","author":"Morales","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neures.2020.11.004_bib0235","doi-asserted-by":"crossref","first-page":"e0185989","DOI":"10.1371\/journal.pone.0185989","article-title":"Striatal astrocytes engulf dopaminergic debris in Parkinson\u2019s disease: a study in an animal model","volume":"12","author":"Morales","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neures.2020.11.004_bib0240","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.expneurol.2017.06.018","article-title":"Clinical approaches to the development of a neuroprotective therapy for PD","volume":"298","author":"Olanow","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neures.2020.11.004_bib0245","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/brain\/awz104","article-title":"Temporal evolution of microglia and \u03b1-synuclein accumulation following foetal grafting in Parkinson\u2019s disease","volume":"142","author":"Olanow","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.neures.2020.11.004_bib0250","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/glia.20691","article-title":"Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson\u2019s disease","volume":"56","author":"Park","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.neures.2020.11.004_bib0255","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2016.09.030","article-title":"IL-6 serum levels are elevated in Parkinson\u2019s disease patients with fatigue compared to patients without fatigue","volume":"370","author":"Pereira","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neures.2020.11.004_bib0260","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","article-title":"Peripheral cytokines profile in Parkinson\u2019s disease","volume":"23","author":"Reale","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neures.2020.11.004_bib0265","doi-asserted-by":"crossref","first-page":"e8784","DOI":"10.1371\/journal.pone.0008784","article-title":"Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson\u2019s disease","volume":"5","author":"Sanchez-Guajardo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neures.2020.11.004_bib0270","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2009.10.062","article-title":"Serum levels of interleukin-6 are elevated in patients with Parkinson\u2019s disease and correlate with physical performance","volume":"468","author":"Scalzo","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neures.2020.11.004_bib0275","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(06)68970-8","article-title":"Mitochondrial disease","volume":"368","author":"Schapira","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.neures.2020.11.004_bib0280","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-017-0182-z","article-title":"Intrastriatal injection of \u03b1-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity","volume":"12","author":"Sorrentino","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neures.2020.11.004_bib0285","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1096\/fj.02-0216fje","article-title":"Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson\u2019s disease","volume":"16","author":"Sriram","year":"2002","journal-title":"Faseb J."},{"key":"10.1016\/j.neures.2020.11.004_bib0290","doi-asserted-by":"crossref","first-page":"e8284","DOI":"10.1073\/pnas.1710442114","article-title":"Modeling Parkinson\u2019s disease pathology by combination of fibril seeds and \u03b1-synuclein overexpression in the rat brain","volume":"114","author":"Thakur","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neures.2020.11.004_bib0295","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson\u2019s disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neures.2020.11.004_bib0300","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.celrep.2014.05.033","article-title":"Alpha-synuclein immunotherapy blocks uptake and templated propagation of misfolded \u03b1-alpha-synuclein and neurodegeneration","volume":"7","author":"Tran","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.neures.2020.11.004_bib0305","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archneur.64.6.836","article-title":"Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease","volume":"64","author":"Wahner","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neures.2020.11.004_bib0310","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neures.2020.11.004_bib0315","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/039463200902200405","article-title":"Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils","volume":"22","author":"Wilms","year":"2009","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.neures.2020.11.004_bib0320","first-page":"325","article-title":"Brain-IL-1 beta triggers astrogliosis through induction of IL-6: inhibition by propranolol and IL-10","volume":"10","author":"Woiciechowsky","year":"2004","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.neures.2020.11.004_bib0325","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00311389","article-title":"Vimentin immunoreactivity in normal and pathological human brain tissue","volume":"84","author":"Yamada","year":"1992","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neures.2020.11.004_bib0330","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","article-title":"Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson\u2019s disease","volume":"91","author":"Yamada","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neures.2020.11.004_bib0335","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat. Med."}],"container-title":["Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010220304843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010220304843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T10:31:36Z","timestamp":1759141896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168010220304843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":67,"alternative-id":["S0168010220304843"],"URL":"https:\/\/doi.org\/10.1016\/j.neures.2020.11.004","relation":{},"ISSN":["0168-0102"],"issn-type":[{"value":"0168-0102","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glial activation precedes alpha-synuclein pathology in a mouse model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neures.2020.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and Japan Neuroscience Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}